期刊文献+

环氧化酶抑制剂干预心肌缺血损伤的实验研究 被引量:3

Effects of cyclooxygenase inhibitor on acute ischemic myocardium in rabbits
下载PDF
导出
摘要 目的 :评价环氧化酶抑制剂对心肌缺血损伤 (AIM)的保护作用。方法 :将成年家兔 (1.8~ 2 .5 kg) 2 4只随机分为正常对照组 (A组 ) ,单纯心肌缺血组 (B组 ) ,心肌缺血加迪克乐克组 (C组 ) ,建立 AIM模型 ,给予相应的干预 ,术后 6 h观察血液学指标 ,缺血心肌的 HE染色及 COX- 2的多克隆抗体免疫组织化学染色进行病理观察。结果 :缺血心肌中 COX- 2高度表达 ,血液学指标示术后 6 h白细胞计数在 B、C组间有明显差异 (P<0 .0 5 ) ,i NOS测定值在A、B组有显著差异 (P<0 .0 5 ) ,MDA、SOD含量在 A、B组间有显著性差异 (P<0 .0 5 ) ,C组应用非选择性环氧化酶抑制剂 ,在术后 6 h白细胞计数升高程度与 A、B组均有显著性差异 (P<0 .0 5 ) ,i NOS测定值与 B组无显著差异(P>0 .0 5 ) ,MDA、SOD含量与 B组差异显著 (P<0 .0 5 )。结论 :缺血心肌存在显著的炎症活动 ,环氧化酶抑制剂对实验性心肌缺血损伤有保护作用。 AIM: To evaluate the effects of cyclooxygenase inhibitor on acute ischemic myocardium(AIM) in rabbits. METHODS: 24 rabbits were randomly divided into 3 groups: group A: normal controls; group B: myocardial ischemia; group C: myocardial ischemia+diclofenac sodium sustained release tablets. The left circumflex arteries of rabbits were ligated to obtain the animal models of AIM for 6 hours in groups B and C. 6 hours after the ligation, we measured the counts of leukocyte of periphery blood and serum MDA,SOD and iNOS;HE and monoclonal antibody immunohistochemistry staining, of ischemic tissues were investigated. RESULTS: The expression of cox-2 in ischemic myocardium increased. 6 hours after the ligation, the difference in the increased count of leukocyte between groups B and C was significant(P<0.05); iNOS was similar in groups B and C(P>0.05). The differences in MDA and SOD were between groups B and C significant(P<0.05). CONCLUSION: Cyclooxygenase inhibitor can protect the ischemic myocardium.
出处 《心脏杂志》 CAS 2004年第2期113-115,共3页 Chinese Heart Journal
关键词 非选择性环氧化酶抑制剂 COX—2 心肌缺血 cyclooxygenase inhibitor myocardial ischemia COX-2
  • 相关文献

参考文献27

  • 1Belton O, Byme D, Kearney D, et al, Cyclooxygenase-1 and -2 dependent prostacyclin formation in patients with arteriosclerosis[J]. Circulation, 9000, 109:840-845.
  • 2Pratico D, Tillmann C, Zhang Z, et al. Acceleration of atherogenesis by COX-1dependent prostaniod formation in low-density lipoprotein receptor knockout mice[J]. PNAS, 2001,98:3358- 3363.
  • 3Michihiko T, Tsunehiko K, shiro H, et al. Arachidonate metabolism in myocardial ischemia and reperfusion[J]. J Mol cell cordial, 1988, 20(suppl Ⅱ): 135-143.
  • 4James K, Jinbao H, Terrance D, et al. Effects of selective Cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries [J]. Circulation, 2001, 104:820 -829.
  • 5Zhang F, Warskulat U, Wettste M, et al. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages[J].Biochem J, 1995,312(Pt 1): 135- 143.
  • 6Smith WL, De Witt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs[J]. Semin Nephrol, 1995,15(3): 179 194.
  • 7Song YG, Kwon HM, Kim JM, et al. Serologic and histopathologic study of chlamydia pneumoniae infection in atherosclerosis : a possible pathogenetic mechanism of atherosclerosis induced by chlamydia pneumoniae [J]. Yonsei Med J, 2000, 41(3): 319-327.
  • 8Song W, Furman BL, Parratt JR. Delayed protection against ischemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of escherichia coli endotoxin[J]. Br J Pharmacol, 1996, 118(8): 2157-2163.
  • 9Feng L,Xia Y, Garcia GE, et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide[J]. J Clin Invest, 1995, 95(4): 1669 -1675.
  • 10Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatary cytokines in patients with chronic stable angina and their reduction by aspirin[J]. Circulation, 1999, 100 : 793- 798.

二级参考文献7

  • 1Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatary cytokines in patients with chronic stable angina and their reduction by aspirin[J]. Circulation, 1999, 100:793-798.
  • 2Engler RL, Dahlgren MD, Morris DD, et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs[J]. Am Physiol, 1986, 251:H314--H328.
  • 3Brown EJ, Kloner RA, Schoen FJ, et al. Scar thinning due to ibuprofen administration after experimental myocardial infarction[J]. Am J Cardiol, 1983, 51:877--883.
  • 4Haji-Ali R, Zareba W, Ezzeddine R,et al. Relation of the leukocyte count recurrent cardiac events in stable patients after myocardial infarction[J]. Am J Cardiog, 2001, 88(11):1221--1224.
  • 5Dinerman JL, Mehta JL, Saldeen TG, et al. Incressed neutrophil elastase release in unstable angina pectoris and acute myocardial infarction[J]. J Am Coil Cardiol, 1990,15:1559--1563.
  • 6Lindsey M, Wedin K, Brown MD, et al. Matrix dependent mechanisms of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion[J].Circulation, 2001,103:2181--2187.
  • 7Hammerman H, Kloner RA, Hale S, et al. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function[J]. Circulation,1983,68,446--452.

共引文献1

同被引文献25

  • 1Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease [ J ].Am J Cardiol,2001, 88:230 -235.
  • 2Eikelboom JW, Hirsh J, Weitz JI, et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [ J ].Circulation,2002, 105:1650 - 1655.
  • 3Ziegler BK, Kristensen SD, Vissinger H, et al. Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: A placebocontrolled pilot trial[J]. Thromb Res,2001,104:175 -180.
  • 4Mukherjee D, Nissen SE, Topol El. Risk of cardiovascular events associated with selective COX-2 inhibitors [ J ]. JAMA, 2001,286 :954 - 959.
  • 5Jones CJ. In vivo effects of meloxicam and aspirin[J]. Am J Vet Res,2002, 63(11) :1527 -1531.
  • 6Herman JK, Huang J, Barrett TD, et al. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries[ J]. Circulation,2001,104:820 - 825.
  • 7Greenberg HE, Gottesdiener K, Huntington M, et al. A new cyclooxygenase-2 inhibitor, rofecoxib, did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers[J]. J Clin Pharmacol,2000,40 : 1509 - 1515.
  • 8Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase -2 [ J ]. N Engl J Med, 2001,345 ( 6 ) : 433 - 442.
  • 9Castro MR, Lutz D, Edelman JL, et al. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularizatian [ J ]. Exp Eye Res, 2004, 79 ( 2 ) : 275 - 285.
  • 10Fischer JW, Hawkiks S, Clowes AW. Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries[J]. J Vasc Surg, 2004, 40(1): 115-122.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部